Article Details

Inhibikase Therapeutics Announces Closing of Follow-On Offering of Common Stock

Retrieved on: 2021-06-18 22:41:15

Tags for this article:

Click the tags to see associated articles and topics

Inhibikase Therapeutics Announces Closing of Follow-On Offering of Common Stock. View article details on hiswai:

Excerpt

... a 45-day option to purchase up to an additional 2,250,000 shares of common stock, at the public offering price less discounts and commissions.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up